首页_副本

Your Strategic Partner for Quality Excellence in Greater China

Trusted “Authorized Delegate” for Sponsors – Navigate Local Complexity, Mitigate Global Risks

Your Strategic Partner for Quality Excellence in Greater China

Trusted “Authorized Delegate” for Sponsors – Navigate Local Complexity, Mitigate Global Risks

Your Strategic Partner for Quality Excellence in Greater China

Trusted “Authorized Delegate” for Sponsors – Navigate Local Complexity, Mitigate Global Risks

XY (Hong Kong) Medical Technology Co., Limited

About us

Founded in 2019, Xun Yuan Clinical Quality Oversight is dedicated to empowering global pharmaceutical, medical device, and IVD sponsors with global regulation

-aligned quality solutions in Greater China. As your trusted “authorized delegate,” we bridge the gap between global compliance standards and local regulatory realities

-delivering efficiency, integrity, and peace of mind.

Pain Point

'Scaling in Greater China is costly'

Building in-house oversight teams drains resources with limited ROI.

'Local compliance is fragmented'

Navigating China’s pharma/device regulations alongside global standards is overwhelming.

'Oversight independence is compromised'

Generic CROs lack conflict-free focus on your study integrity.

高效能源管理系统

Efficient energy management system

智能驾驶辅助功能

Intelligent driver assistance system

轻量化车身设计

Lightweight body design

Solution

XY (Hong Kong) Medical Technology Co., Limited

About us

Founded in 2019, Xun Yuan Clinical Quality Oversight is dedicated to empowering global pharmaceutical, medical device, and IVD sponsors with global regulation-aligned quality solutions in Greater China. As your trusted “authorized delegate,” we bridge the gap between global compliance standards and local regulatory realities – delivering efficiency, integrity, and peace of mind.

Authorized Delegate Service

Act as your extension to ensure end-to-end compliance

Pain Point

Card1

'Scaling in Greater China is costly' – Building in-house oversight teams drains resources with limited ROI.

Card2

'Local compliance is fragmented' – Navigating China’s pharma/device regulations alongside global standards is overwhelming.

Card3

'Oversight independence is compromised' – Generic CROs lack conflict-free focus on your study integrity.

Why Xun Yuan

Zero Turnover (2019+)

10+ Years Avg. Expert Experience

2-Week Rapid Deployment

Conflict-Free

Client Feedback

Global Pharma Director, Oncology

“Xun Yuan’s authorized delegate support turned our China compliance challenges into a competitive advantage. Their local insights ensured seamless Global Regulation alignment – no delays, no surprises.”

Ready to Simplify Your Greater China Trials?

Contact Our Experts

Full Name *
Job Title *
Company Name *
Industry *
Primary Need *
Regulation Compliance GCP/GCLP Audit Authorized Delegate Service Inspection Readiness Other

Primary Need *
Message
Email Address *
Phone Number
Submit